IL81933A - Asymmetrical ester derivatives of 1,4-dihydro-2,6-dimethyl-4-phenyl-pyridine-3,5-dicarboxylic acid,their preparation and pharmaceutical compositions containing them - Google Patents
Asymmetrical ester derivatives of 1,4-dihydro-2,6-dimethyl-4-phenyl-pyridine-3,5-dicarboxylic acid,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL81933A IL81933A IL81933A IL8193387A IL81933A IL 81933 A IL81933 A IL 81933A IL 81933 A IL81933 A IL 81933A IL 8193387 A IL8193387 A IL 8193387A IL 81933 A IL81933 A IL 81933A
- Authority
- IL
- Israel
- Prior art keywords
- dicarboxylic acid
- phenyl
- group
- dihydro
- pyridine
- Prior art date
Links
- -1 ester derivatives of 1,4-dihydro-2,6-dimethyl-4-phenyl-pyridine-3,5-dicarboxylic Chemical class 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 150000002148 esters Chemical class 0.000 abstract 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- 229940030600 antihypertensive agent Drugs 0.000 abstract 1
- 239000002220 antihypertensive agent Substances 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/113—Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Photoreceptors In Electrophotography (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Coloring (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Laminated Bodies (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL94503A IL94503A0 (en) | 1986-04-02 | 1990-05-25 | Esters of alpha(8-aza-1,4-dioxa-spiro(4,5)decan-2-yl)acetic acid |
| IL94502A IL94502A0 (en) | 1986-04-02 | 1990-05-25 | Preparation of methyl,1,2-dihydroxypropan-3-yl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8604685A FR2596760B1 (fr) | 1986-04-02 | 1986-04-02 | Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL81933A0 IL81933A0 (en) | 1987-10-20 |
| IL81933A true IL81933A (en) | 1991-06-30 |
Family
ID=9333794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL81933A IL81933A (en) | 1986-04-02 | 1987-03-18 | Asymmetrical ester derivatives of 1,4-dihydro-2,6-dimethyl-4-phenyl-pyridine-3,5-dicarboxylic acid,their preparation and pharmaceutical compositions containing them |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US4806544A (cs) |
| EP (1) | EP0240398B1 (cs) |
| JP (1) | JPS6317883A (cs) |
| KR (1) | KR900005956B1 (cs) |
| CN (1) | CN1015460B (cs) |
| AT (1) | ATE63555T1 (cs) |
| AU (2) | AU590690B2 (cs) |
| CS (1) | CS268828B2 (cs) |
| DD (2) | DD263291A5 (cs) |
| DE (1) | DE3770037D1 (cs) |
| DK (1) | DK161787A (cs) |
| ES (1) | ES2028886T3 (cs) |
| FI (1) | FI86302C (cs) |
| FR (1) | FR2596760B1 (cs) |
| GR (1) | GR3002267T3 (cs) |
| HU (2) | HUT53080A (cs) |
| IL (1) | IL81933A (cs) |
| NO (1) | NO167029C (cs) |
| NZ (1) | NZ219758A (cs) |
| OA (1) | OA08508A (cs) |
| PT (1) | PT84560B (cs) |
| SU (1) | SU1586515A3 (cs) |
| TN (1) | TNSN87043A1 (cs) |
| YU (2) | YU57287A (cs) |
| ZA (1) | ZA872258B (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4092406A1 (cs) * | 1989-12-22 | 1993-04-01 | ||
| DE4125271A1 (de) * | 1991-07-31 | 1993-02-11 | Bayer Ag | Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester |
| WO1993006082A1 (en) * | 1991-09-13 | 1993-04-01 | Merck & Co., Inc. | Process for the preparation of 4-substituted-1,4-dihydropyridines |
| EP2410854B1 (en) * | 2009-03-27 | 2016-06-29 | Council of Scientific & Industrial Research | Substituted 1, 4-dioxa-8-azaspiro ý4,5¨decanes useful as fungicides and a process for the preparation thereof |
| WO2012123966A1 (en) | 2011-03-04 | 2012-09-20 | Arch Pharmalabs Limited | Process for the preparation of 4 -substituted -1, 4-dihydropyridines |
| CN102796111B (zh) * | 2012-09-10 | 2014-09-24 | 贵州大学 | 氧氮杂螺环酰胺基团的羧(磺)酸酯类化合物及制备方法和用途 |
| CN104860873A (zh) * | 2015-05-28 | 2015-08-26 | 石家庄学院 | 一种(s)-1,4-二氢吡啶钙离子拮抗剂的制备方法 |
| CN108430989B (zh) * | 2015-10-13 | 2021-10-08 | 轩竹生物科技有限公司 | 1,4-二氢吡啶-3,5-二羧酸酯衍生物的制备方法及中间体 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670824C3 (de) * | 1967-03-20 | 1978-08-03 | Bayer Ag, 5090 Leverkusen | 1,4-Dihydropyridin-33-dicarbonsäurealkylester |
| GB1245087A (en) * | 1967-10-26 | 1971-09-02 | Wyeth John & Brother Ltd | Heterocyclic compounds |
| JPS4932542B1 (cs) * | 1970-08-17 | 1974-08-31 | ||
| GB1591089A (en) * | 1976-12-17 | 1981-06-10 | Fujisawa Pharmaceutical Co | 1,4-dihydropyridine derivatives and process for preparation thereof |
| US4250312A (en) * | 1979-12-28 | 1981-02-10 | Argus Chemical Corp. | Process for preparing 4-piperidone spiroketal compounds |
| US4250313A (en) * | 1980-02-01 | 1981-02-10 | Argus Chemical Corp. | Process for preparing 4-piperidone spiroketal compounds |
| DE3208628A1 (de) * | 1982-03-10 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| WO1983003249A1 (fr) * | 1982-03-17 | 1983-09-29 | Yoshitomi Pharmaceutical | Derives de 1,4-dihydropyridine-3,5-dicarboxylate |
| JPS58159462A (ja) * | 1982-03-17 | 1983-09-21 | Yoshitomi Pharmaceut Ind Ltd | １，４−ジヒドロピリジン−３，５−ジカルボン酸エステル誘導体 |
| FR2577552B1 (fr) * | 1985-02-20 | 1987-09-04 | Sori Soc Rech Ind | Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique |
-
1986
- 1986-04-02 FR FR8604685A patent/FR2596760B1/fr not_active Expired
-
1987
- 1987-03-18 US US07/027,262 patent/US4806544A/en not_active Expired - Fee Related
- 1987-03-18 ES ES198787400598T patent/ES2028886T3/es not_active Expired - Lifetime
- 1987-03-18 AT AT87400598T patent/ATE63555T1/de not_active IP Right Cessation
- 1987-03-18 EP EP87400598A patent/EP0240398B1/fr not_active Expired - Lifetime
- 1987-03-18 IL IL81933A patent/IL81933A/xx unknown
- 1987-03-18 DE DE8787400598T patent/DE3770037D1/de not_active Expired - Fee Related
- 1987-03-19 AU AU70410/87A patent/AU590690B2/en not_active Ceased
- 1987-03-24 NZ NZ219758A patent/NZ219758A/xx unknown
- 1987-03-25 FI FI871316A patent/FI86302C/fi not_active IP Right Cessation
- 1987-03-25 TN TNTNSN87043A patent/TNSN87043A1/fr unknown
- 1987-03-26 PT PT84560A patent/PT84560B/pt not_active IP Right Cessation
- 1987-03-27 ZA ZA872258A patent/ZA872258B/xx unknown
- 1987-03-30 DK DK161787A patent/DK161787A/da not_active IP Right Cessation
- 1987-03-31 OA OA59099A patent/OA08508A/xx unknown
- 1987-03-31 NO NO871339A patent/NO167029C/no unknown
- 1987-04-01 KR KR1019870003078A patent/KR900005956B1/ko not_active Expired
- 1987-04-01 YU YU00572/87A patent/YU57287A/xx unknown
- 1987-04-01 DD DD87301364A patent/DD263291A5/de not_active IP Right Cessation
- 1987-04-01 SU SU874202348A patent/SU1586515A3/ru active
- 1987-04-01 DD DD87325139A patent/DD278793A5/de not_active IP Right Cessation
- 1987-04-01 HU HU893897A patent/HUT53080A/hu unknown
- 1987-04-01 CS CS872292A patent/CS268828B2/cs unknown
- 1987-04-01 HU HU871403A patent/HU199479B/hu unknown
- 1987-04-01 CN CN87102452A patent/CN1015460B/zh not_active Expired
- 1987-04-02 JP JP62083694A patent/JPS6317883A/ja active Pending
-
1988
- 1988-03-09 YU YU480/88A patent/YU44714B/xx unknown
- 1988-09-22 US US07/249,402 patent/US4900833A/en not_active Expired - Fee Related
-
1989
- 1989-09-11 AU AU41263/89A patent/AU610753B2/en not_active Ceased
-
1991
- 1991-07-05 GR GR91400959T patent/GR3002267T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE122009000040I2 (de) | Naphthalin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen. | |
| ATE130604T1 (de) | Neue arylethylaminderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| NZ222106A (en) | Dihydropyridine derivatives and pharmaceutical compositions | |
| DK0490566T3 (da) | Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler | |
| SE8403801L (sv) | Nya bensotiazepiner med kardiovaskuler anvendbarhet, forfarande for framstellning derav och farmaceutiska kompositioner som innehaller dem | |
| IL81933A (en) | Asymmetrical ester derivatives of 1,4-dihydro-2,6-dimethyl-4-phenyl-pyridine-3,5-dicarboxylic acid,their preparation and pharmaceutical compositions containing them | |
| ES8307260A1 (es) | Procedimiento para la obtencion de derivados de trifluormetil-fenoxifenil-silicio. | |
| ATE32221T1 (de) | 3 n-substituierte 3,4-dihydropyrimidinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen. | |
| KR870005641A (ko) | 고혈압 치료용 조성물 | |
| GR3017348T3 (en) | Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same. | |
| DE3866292D1 (de) | Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
| YU158385A (en) | Process for obtaining derivatives of 2-pyridine thioles | |
| DK469285D0 (da) | Thiadiazolderivater, der indvirker paa centralnervesystemet, fremgangsmaade til fremstilling deraf og midler indeholdende derivaterne | |
| IL106564A (en) | Tetrahydronaphthalene derivatives their preparation and pharmaceutical compositions containing them | |
| ES2123038T3 (es) | Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| IL81565A (en) | Dihydropyridine-dicarboxylic acid esters,their preparation and pharmaceutical compositions containing them | |
| SE8803932D0 (sv) | New octahydro indenofuran derivatives, their preparation and therapeutic composition containing the same |